PepGen

PepGen Share Buybacks

The Share Buybacks of PepGen (PEPG) as of Oct 17, 2026 is 114.89 M USD.

Share Buybacks

114.89 MUSD

Last updated:

Share Buybacks of PepGen is 2022 114.89 M USD. Share Buybacks of PepGen was 2021 - USD. It decreases by % lower compared to the previous year.

The PepGen Share Buybacks history

The PepGen Share Buybacks history
YEARShare BuybacksYoY
114.89 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PepGen Stock analysis

What does PepGen do? PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees. PepGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PepGen stock

Share Buybacks of PepGen is 114.89 M USD in 2022.

On Eulerpool you can find the complete historical development of Share Buybacks PepGen since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's PepGen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — PepGen

All Key Metrics — PepGen